Maintaining 340B drug pricing compliance requires more than getting discounted medications. Healthcare organizations must have clear policies, accurate records, strong internal controls, and regular monitoring to make sure 340B drugs are used correctly.
For 340B covered entities, ongoing compliance helps reduce the risk of diversion, duplicate discounts, inaccurate records, and problems during a federal audit.
What Is 340B Drug Pricing Compliance?
340B drug pricing compliance means following the rules of the 340B Drug Pricing Program when purchasing, dispensing, and managing covered outpatient drugs.
The program allows eligible healthcare organizations to purchase certain outpatient drugs at discounted prices. In return, covered entities must meet specific program requirements and maintain records that support their compliance.
Common areas of 340B compliance include:
Maintaining accurate eligibility and registration information
Preventing drug diversion
Preventing duplicate discounts
Managing contract pharmacies appropriately
Keeping accurate purchasing and dispensing records
Monitoring program activity
Maintaining policies and procedures
Preparing for HRSA audits
Compliance is an ongoing responsibility. It should be part of normal pharmacy, financial, and operational processes rather than something an organization addresses only before an audit.
Why Does 340B Compliance Matter?
A weak compliance process can create financial, operational, and regulatory problems.
For example, an organization may have a process that looks correct on paper but still experience issues because staff are not following it consistently. A system may also contain inaccurate patient, prescription, purchasing, or inventory information.
Regular 340B program monitoring helps identify these problems earlier.
It also gives leadership a clearer view of how the program is being managed and whether existing controls are working as intended.
Build Clear 340B Policies and Procedures
One of the first steps in effective 340B program management is creating clear written policies.
Policies should explain how the organization handles important activities such as:
Patient eligibility
Drug purchasing
Inventory management
Contract pharmacy operations
Prescription processing
Duplicate discount prevention
Diversion prevention
Recordkeeping
Internal audits
Issue escalation and corrective action
Policies should also reflect the organization's actual workflows.
A policy that staff cannot realistically follow will not provide much protection. Healthcare organizations should review procedures when workflows, systems, vendors, pharmacy arrangements, or program requirements change.
Monitor Eligibility and Patient Requirements
Maintaining accurate information about the covered entity and eligible patients is a key part of 340B program compliance.
Organizations should have controls that help confirm whether prescriptions and patients meet applicable 340B requirements.
This becomes especially important when an organization operates multiple locations, departments, or contract pharmacy relationships.
Regular reviews can help identify unusual activity, data errors, or situations that need further investigation.
Prevent Drug Diversion and Duplicate Discounts
Drug diversion and duplicate discounts are two major areas of concern in the 340B program.
Drug diversion generally involves using a 340B-purchased drug for an individual who does not meet the applicable 340B patient requirements or otherwise using the drug outside permitted program rules.
Duplicate discounts can occur when the same drug is subject to both a 340B discount and a Medicaid rebate.
Organizations should establish controls to detect and prevent these situations. This may involve reviewing claims, purchasing data, dispensing records, payer information, and other relevant data.
The exact controls will depend on the organization's structure and systems.
Make 340B Compliance Monitoring Routine
340B compliance monitoring should not be limited to an annual review.
Regular monitoring can help organizations find issues while they are still manageable. A practical monitoring process may include reviewing:
340B purchasing activity
Dispensing records
Patient eligibility
Inventory transactions
Contract pharmacy activity
Medicaid billing and payer information
Exception reports
Changes in locations or services
Previous audit findings
The frequency of each review can vary based on the organization's size, risk profile, systems, and operations.
The key is consistency. A documented monitoring schedule gives staff a clear process to follow and helps leadership understand where risks may exist.
Keep Records Audit Ready
340B audit readiness should be part of everyday program management.
Healthcare organizations should maintain records that allow them to explain how their 340B processes work and demonstrate that those processes are being followed.
This may include policies, purchasing records, dispensing information, patient eligibility documentation, inventory records, contract pharmacy documentation, internal review results, and corrective action records.
A good approach is to organize documentation before it is needed.
When records are spread across multiple systems or departments, responding to an audit can become unnecessarily difficult. Assigning responsibility for maintaining and retrieving key documentation can make the process much easier.
Use Internal Audits to Find Problems Early
Internal audits can provide an independent check of the organization's 340B processes.
A review may focus on a specific risk area or examine the program more broadly. For example, an organization might review patient eligibility, contract pharmacy transactions, purchasing records, or duplicate discount controls.
The goal is not simply to find mistakes. It is to understand why an issue occurred and determine whether the underlying process needs to change.
When an issue is identified, the organization should document the finding, determine its impact, correct the problem, and monitor the process afterward.
Train Staff and Assign Clear Responsibilities
340B compliance depends on people as much as systems.
Pharmacy teams, compliance staff, finance teams, IT staff, and other employees may all interact with 340B processes. Each person should understand their role and know what to do when something does not look right.
Training should cover the responsibilities that apply to each employee's position rather than giving everyone the same general information.
Organizations should also make ownership clear. Someone should be responsible for coordinating the overall 340B program, while individual departments understand their specific responsibilities.
Use Technology Carefully
Technology can support 340B compliance solutions, but software alone cannot create a compliant program.
Organizations may use technology to connect purchasing, pharmacy, patient, billing, inventory, and reporting data. Automated alerts and exception reports can also help identify transactions that require review.
However, technology needs proper configuration and oversight.
Healthcare organizations should regularly review system rules, user access, data quality, interfaces, and reports. A system can produce consistent results while still producing the wrong results if its underlying rules or data are incorrect.
How Can Organizations Improve 340B Compliance?
A practical approach is to treat compliance as a continuous cycle:
1. Establish policies
Define how the organization will meet applicable 340B requirements.
2. Assign responsibility
Make sure staff know who owns each part of the process.
3. Monitor activity
Review transactions and reports regularly.
4. Identify risks
Look for unusual activity, data problems, and process weaknesses.
5. Correct issues
Document findings and take appropriate corrective action.
6. Recheck the process
Confirm that the correction worked and continue monitoring it.
Organizations that need additional support can also work with experienced 340B advisors. A specialized provider such as NorthArc Health can help healthcare organizations with areas such as 340B compliance, program management, monitoring, and audit preparation.
Common 340B Compliance Questions
How often should a healthcare organization review its 340B program?
There is no single review schedule that fits every organization. Monitoring frequency should reflect the organization's operations and risk areas. Regular reviews are generally more useful than waiting until an audit or major problem occurs.
What are common 340B compliance risks?
Common risks include patient eligibility errors, drug diversion, duplicate discounts, inaccurate records, contract pharmacy issues, weak internal controls, and failure to follow established procedures.
Who is responsible for 340B compliance?
Responsibility is shared across the organization. Leadership, pharmacy, compliance, finance, IT, and other relevant teams may all have specific roles. Clear ownership helps prevent gaps.
What is 340B audit readiness?
340B audit readiness means having the policies, records, controls, and supporting documentation needed to demonstrate that the organization is following applicable program requirements.
Conclusion
Strong 340B drug pricing compliance comes from consistent processes, accurate data, regular monitoring, and clear accountability.
Healthcare organizations should not view compliance as a one-time project. Ongoing 340B program monitoring, staff training, internal reviews, accurate documentation, and timely corrective action can help organizations identify problems before they become larger issues.
A well-managed 340B program protects the organization while supporting the purpose of the program: helping eligible healthcare providers stretch their resources and serve their communities.
